HUNTINGTON BEACH, Calif.,
Oct. 17, 2016 /PRNewswire/
-- (Booth #504) -- West Pharmaceutical Services, Inc.
(NYSE: WST), a global leader in innovative solutions for injectable
drug administration and delivery, today announced that it will
participate in several educational sessions, scientific posters,
and presentations at the 2016 PDA Universe of Pre-filled Syringes
& Injection Devices, taking place October 17-18 in Huntington Beach, California. West will share
advances in drug containment, self-administration systems, and
patient adherence, and will co-present with Amgen
(https://www.amgen.com) as well as Noble
(http://www.gonoble.com/onboarding/). Additionally, West will
showcase high-quality packaging technologies and drug delivery
solutions at booth #504.
"As the number of biologic medicines continues to rise, West is
working with our customers to provide the highest quality drug
containment solutions, as well as innovative drug delivery
technologies that can meet the needs of patients and healthcare
providers in this evolving marketplace," said Eric Resnick, VP & Chief Technology Officer
at West. "At this year's meeting, we look forward to presenting
alongside our customers and collaboration partners to share how
these successful relationships have resulted in drug containment
and delivery advancements for patients."
This year, West announced details of two collaborations with
global biotechnology leader Amgen Inc. In February of 2016, West
announced that Amgen had selected West's Daikyo Crystal Zenith®
vials—in conjunction with West's FluroTec® stoppers—to contain
Amgen's FDA-approved therapy IMLYGIC™ (talimogene laherparepvec).
In July of 2016, Amgen announced the U.S. approval of its Repatha®
(evolocumab) Pushtronex system (on-body infusor with
prefilled cartridge) based on West's SmartDose® drug delivery
technology. Leaders from West and Amgen will present a case study
around their collaboration associated with the Repatha program, as
well as a co-presentation on the benefits and challenges of
approval of a polymer container system compared with traditional
glass containers.
West will also announce the availability of a multisensory-based
educational and training program for West's SmartDose technology
platform. This new training system is the result of a collaboration
with Noble®, a leader in patient-centric onboarding and training.
This new training system signifies a continuation of West's
strategy to enhance the overall patient experience, and will
complement West's existing relationships with Insight Product
Development and Healthprize Technologies. Insight provides
user-centric research and design inputs, and Healthprize provides a
Software-as-a-Service platform to help improve patient adherence
through motivation and education. West and Noble will co-present
the results of this end-to-end patient training solution, and the
collaboration between West and each of the three other companies
will be featured at the respective booths of each company.
During the conference, West will lead the following educational
sessions:
- October 17, 11:15 a.m. – "Effective Patient Training and
Onboarding for Wearable Injection Devices," Chris Evans, Vice President, Research &
Innovation at West, and Mike Siemer,
Director of Design & Engineering at Noble.
- October 17, 1:30 p.m. – "Collaborative Partnership
between Device Manufacturers and Pharmaceutical/Biopharma Companies
to Ensure Optimized Combination Products for Injectable Drugs,"
Tom McLean, Vice President, Delivery
Systems, Research & Development at West, and Bill Rich, Vice President, Device Technologies
at Amgen.
- October 18, 11:15
a.m. – "Polymer Container Systems – Perspective from Biopharma
Drug & Container Manufacturers," Scott
Young, Ph.D., Vice President, Container Systems at West, and
Ronald Forster, Ph.D., Executive
Director, Device & Final Drug Product Technologies at
Amgen.
Additionally, West will present two scientific posters during
refreshment breaks on Monday and Tuesday:
- October 17 – "Component
Selection Strategies for PFS: Risk Mitigation, Performance, and
Larger Injection Volume Driving Innovative Solutions," Royce Brockett, Senior Manager, Product
Management at West.
- October 18 –
"Cartridge-Based Containment Systems: A Review of Component Fit and
Functional Performance Data for Plungers and Lined Seals,"
Andrea Straka, Supervisor,
Scientific Affairs at West.
Finally, West will participate in the following educational
workshops after the conference:
- October 19, 8:30 a.m. to 10 a.m. — "Human Factors/Risk
Management"
Moderator: Diane Paskiet, Director,
Scientific Affairs at West.
Panelist: Chris Evans, Vice
President, Research & Innovation at West.
- October 20, 8:30 a.m. to 4 p.m. — "Understanding Product
Options, User Needs and Fill-Finish Requirements for Nested Format
Syringes, Cartridge Containers and Drug Delivery Systems,"
Tibor Hlobik, Sr. Director, Product
Management, Prefilled Systems & Delivery at West.
- October 21, 8:30 a.m. to 4 p.m. — "Essential Elements of
Extractables and Leachables: From Material Selection to Final
Report," Diane Paskiet, Director,
Scientific Affairs at West.
West will showcase several innovative drug delivery system and
packaging component technologies at booth #504, including:
- 1-3mL NovaPure® plungers – High-quality components for
higher-volume pre-filled delivery systems, designed using Quality
by Design (QbD) principles to reduce particulate and ensure
consistency of delivery.
- SmartDose® technology platform – An integrated drug
delivery system that adheres to the patient's body, usually on the
abdomen, so patients can be hands free while self-administering
medication in accordance with their prescribed treatment.
- Daikyo Crystal Zenith® – A cyclic olefin polymer
containment and delivery system designed as a high-performance
alternative to glass. It is an integrated lifecycle solution that
is designed to maintain drug safety, purity and efficacy from
development through to commercialization.
- Westar® cartridge plungers – Ready-to-Use and
Ready-to-Sterilize cartridge components manufactured for
consistency and quality to reduce the risk of variability and its
potential effects on drug safety and efficacy.
For more information, please visit West at booth #504 at the PDA
Universe of Pre-filled Syringes & Injection Devices or online
at www.westpharma.com.
Certain forward-looking statements are included in this release.
These statements reflect management's current expectations
regarding future events and operating performance and speak only as
of the date of this release. There is no certainty that West's
Daikyo Crystal Zenith® with FluroTec® stoppers or SmartDose®
technology platform will achieve any level of commercial success.
These forward-looking statements involve a number of risks and
uncertainties. For a description of certain additional factors that
could cause West's future results to differ from those expressed in
any such forward-looking statements, see Item 1A, entitled "Risk
Factors," in West's Annual Report on Form 10-K for the year ended
December 31, 2015.
About West
West Pharmaceutical Services, Inc. is a
leading manufacturer of packaging components and delivery systems
for injectable drugs and healthcare products. Working by the side
of its customers from concept to patient, West creates products
that promote the efficiency, reliability and safety of the world's
pharmaceutical drug supply. West is headquartered in Exton, Pennsylvania, and supports its
customers from locations in North and South America, Europe, Asia
and Australia. West's 2015 sales
of $1.4 billion reflect the daily use
of approximately 110 million of its components and devices, which
are designed to improve the delivery of healthcare to patients
around the world.
West and the diamond logo and By your side for a healthier
world™ are registered trademarks or trademarks of West
Pharmaceutical Services, Inc., in the
United States and other jurisdictions.
Daikyo Crystal Zenith® is a registered trademark of Daikyo
Seiko, Ltd. Daikyo Crystal Zenith technology is licensed from
Daikyo Seiko, Ltd.
FluroTec® technology is licensed from Daikyo Seiko,
Ltd.
Repatha® and Pushtronex™ are registered trademarks of Amgen
Inc.
Media Contact:
Tiffany
Burke
Global Communications, West Pharmaceutical Services
+ 1-610-594-3231
Tiffany.Burke@westpharma.com
Logo -
http://photos.prnewswire.com/prnh/20131029/NE05658LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/west-to-showcase-expertise-in-injectable-drug-containment-and-delivery-at-pda-universe-of-pre-filled-syringes--injection-devices-300345273.html
SOURCE West Pharmaceutical Services, Inc.